Locally advanced head and neck squamous cell carcinoma, LAHNSCC, LA-HNSCC, LA HNSCC, PD-1, PDL-1, PD1, PDL1, Nivolumab, Pembrolizumab, Radiation enhances MHC class I surface expression,calreticulin expression, and release of HMGB1, GORTEC 2015-01 (PembroRad) Randomized Trial in Cisplatin-Unfit Patients, JAVELIN Head and Neck 100: Schema, KEYNOTE 412